Home › A Biotech Beatdown From The Biogen Perspective
 

Keywords :   


A Biotech Beatdown From The Biogen Perspective

2015-10-11 02:43:30| Biotech - Topix.net

The company has a $1.2 billion war chest which it can use to buy another company, buy its own shares, or issue a small dividend. I believe the bar is set pretty low for the company for this third quarter and can potentially be a catalyst to drive the stock up in the near future.

Tags: perspective biotech biogen

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
01.07Atlantic Tropical Weather Outlook
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 9A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Depression Three Graphics
01.07Tropical Depression Three Public Advisory Number 1A
01.07Summary for Tropical Depression Three (AT3/AL032024)
01.07Eastern North Pacific Tropical Weather Outlook
More »